Literature DB >> 18689858

The role of the orbitofrontal cortex and medial striatum in the regulation of prepotent responses to food rewards.

M S Man1, H F Clarke, A C Roberts.   

Abstract

An impairment in learning to inhibit prepotent responses to positive stimuli is associated with damage to the orbitofrontal cortex (OFC) in rats, monkeys, and humans performing discrimination reversal, extinction, and detour reaching tasks. In contrast, a recent study showed that OFC-lesioned rhesus monkeys could learn to select the smaller of 2 quantities of food reward in order to receive the larger reward, at an equivalent rate to controls, despite the requirement to inhibit a prepotent response. Given this result, the aim of the present study was to further specify the contexts under which the OFC regulates responding and to identify additional components of limbic circuitry that contribute to such regulation. Marmosets with lesions of the OFC and medial striatum (MS), but not the amygdala, made more prepotent responses to a clear Perspex box containing high incentive food before learning to choose the box containing low incentive food, to obtain reward. However, having learned the incongruent incentive discrimination OFC- and MS-lesioned monkeys were impaired upon reversal of the reward contingencies, repeatedly selecting the previously rewarded low incentive object. These findings identify the critical contribution of the OFC and MS in the regulation of responding by affective cues.

Entities:  

Mesh:

Year:  2008        PMID: 18689858     DOI: 10.1093/cercor/bhn137

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  16 in total

1.  3-D cytoarchitectonic parcellation of human orbitofrontal cortex correlation with postmortem MRI.

Authors:  Harry B M Uylings; Ernesto J Sanz-Arigita; Koos de Vos; Chris W Pool; Paul Evers; Grazyna Rajkowska
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

Review 2.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

3.  Differential brain activity during emotional versus nonemotional reversal learning.

Authors:  Kaoru Nashiro; Michiko Sakaki; Lin Nga; Mara Mather
Journal:  J Cogn Neurosci       Date:  2012-05-23       Impact factor: 3.225

Review 4.  Reversal learning as a measure of impulsive and compulsive behavior in addictions.

Authors:  Alicia Izquierdo; J David Jentsch
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

Review 5.  Mechanisms of reward circuit dysfunction in psychiatric illness: prefrontal-striatal interactions.

Authors:  Maia Pujara; Michael Koenigs
Journal:  Neuroscientist       Date:  2013-08-07       Impact factor: 7.519

Review 6.  Reward mechanisms in obesity: new insights and future directions.

Authors:  Paul J Kenny
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

Review 7.  Learning theory: a driving force in understanding orbitofrontal function.

Authors:  Michael A McDannald; Joshua L Jones; Yuji K Takahashi; Geoffrey Schoenbaum
Journal:  Neurobiol Learn Mem       Date:  2013-06-14       Impact factor: 2.877

8.  Selective aspiration or neurotoxic lesions of orbital frontal areas 11 and 13 spared monkeys' performance on the object discrimination reversal task.

Authors:  Andy Kazama; Jocelyne Bachevalier
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

Review 9.  Neural circuitry associated with risk for alcohol use disorders.

Authors:  Kevin D Tessner; Shirley Y Hill
Journal:  Neuropsychol Rev       Date:  2009-08-15       Impact factor: 7.444

10.  Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine.

Authors:  Alicia Izquierdo; Annabelle M Belcher; Lori Scott; Victor A Cazares; Jack Chen; Steven J O'Dell; Melissa Malvaez; Tiffany Wu; John F Marshall
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.